Spyre Therapeutics, Inc. (SYRE)
106.65
+0.16
(+0.15%)
USD |
NASDAQ |
Aug 24, 16:00
107.01
+0.36
(+0.34%)
After-Hours: 07:37
Spyre Therapeutics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 1.664 |
| December 31, 2023 | 0.4595 |
| September 30, 2023 | -1.577 |
| June 30, 2023 | -0.9724 |
| March 31, 2023 | 0.1317 |
| December 31, 2022 | 0.0923 |
| September 30, 2022 | 0.0703 |
| June 30, 2022 | 0.057 |
| March 31, 2022 | 0.08 |
| December 31, 2021 | 0.0653 |
| September 30, 2021 | 0.0506 |
| June 30, 2021 | 0.0445 |
| March 31, 2021 | 0.043 |
| December 31, 2020 | 0.0395 |
| September 30, 2020 | 0.0388 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.0323 |
| March 31, 2020 | 0.1193 |
| December 31, 2019 | 0.0853 |
| September 30, 2019 | 0.0654 |
| June 30, 2019 | 0.0524 |
| March 31, 2019 | 0.0066 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AbbVie, Inc. | -11.93 |
| vTv Therapeutics, Inc. | 0.00 |
| BridgeBio Pharma, Inc. | -1.353 |
| Praxis Precision Medicines, Inc. | 0.0008 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.173B |
| Total Liabilities (Quarterly) | 71.86M |
| Shareholders Equity (Quarterly) | 1.101B |
| Current Ratio | 18.53 |